Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 3, 2017 11:25 AM 2 min read

A Big Move Into A New Ex-U.S. ETF

by Todd Shriber, ETF Professor Benzinga Staff Writer
Follow

Investors' well-documented affinity for ex-U.S. developed markets exchange traded funds (ETFs) this year is not limited to established funds. The iShares Core MSCI International Developed Markets ETF (NYSEARCA:IDEV) debuted in March and is off to a stellar start.

 

Since its March debut, IDEV has been one of this year's more successful new equity ETFs, but the fund's stellar start has gotten a big boost in recent days. For the week ending Nov. 1, IDEV took in nearly $617 million in new assets, a total surpassed by just four other ETFs over that period. 

 

IDEV had $713.3 million in assets under management as of Nov. 1, meaning the ETF needed barely more than eight months of work to hit that level.

 

Good Timing

 

Not all new ETFs have the benefit of good timing. IDEV certainly did. The ETF came to market at a time when investors were displaying an overt preference for low-cost exposure to ex-U.S. developed markets, a theme that has been prevalent for the bulk of this year.

 

Three of the top 10 asset-gathering ETFs — including two of the top three — on a year-to-date basis are inexpensive funds tracking stocks in developed markets outside the U.S. This underscores the point that IDEV was well-timed to the community of low-cost international equity ETFs.

 

IDEV charges just 0.07 percent per year, or $7 on a $10,000 investment, making it one of the least expensive international equity ETFs on the market today.

 

More Details

 

IDEV holds over 1,200 stocks and tracks the MSCI WORLD ex USA IMI Index. That index is different from the widely followed MSCI EAFE Index in that IDEV's benchmark features exposure to Canada, whereas the MSCI EAFE Index does not. Canada is IDEV's fourth-largest geographic allocation, at a weight of almost 8.7 percent.

 

Japan and the U.K. combine for nearly 39 percent of IDEV's weight. IDEV features exposure to six Eurozone nations, led by a combined weight of 17.4 percent to France and Germany.

 

IDEV's largest sector weight is 21.3 percent to financial services. Industrial and consumer discretionary names combine for over 27 percent of the rookie ETF's lineup. IDEV is up 13.5 percent since coming to market, which slightly trails the MSCI EAFE Index over that period.

 

Related Links:

 

Big Apple Bets On QQQ.

 

Reversing The S&P 500

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Long IdeasNewsSpecialty ETFsEurozoneMarketsTrading IdeasETFs
EFA Logo
EFAiShares MSCI EAFE ETF
Not Available-%
Overview
EFA Logo
EFAiShares MSCI EAFE ETF
Not Available-%
Overview
Comments
Loading...